BGM
Price
$10.03
Change
+$0.27 (+2.77%)
Updated
Jul 3 closing price
Capitalization
24.66M
NDVAF
Price
$0.02
Change
-$0.01 (-33.33%)
Updated
Jun 12 closing price
Capitalization
3.51M
Interact to see
Advertisement

BGM vs NDVAF

Header iconBGM vs NDVAF Comparison
Open Charts BGM vs NDVAFBanner chart's image
BGM Group
Price$10.03
Change+$0.27 (+2.77%)
Volume$27.78K
Capitalization24.66M
Indiva
Price$0.02
Change-$0.01 (-33.33%)
Volume$510.99K
Capitalization3.51M
BGM vs NDVAF Comparison Chart in %
Loading...
BGM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BGM vs. NDVAF commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BGM is a Hold and NDVAF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (BGM: $10.03 vs. NDVAF: $0.02)
Brand notoriety: BGM and NDVAF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: BGM: 51% vs. NDVAF: 100%
Market capitalization -- BGM: $24.66M vs. NDVAF: $3.51M
BGM [@Pharmaceuticals: Other] is valued at $24.66M. NDVAF’s [@Pharmaceuticals: Other] market capitalization is $3.51M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.79B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BGM’s FA Score shows that 1 FA rating(s) are green whileNDVAF’s FA Score has 0 green FA rating(s).

  • BGM’s FA Score: 1 green, 4 red.
  • NDVAF’s FA Score: 0 green, 5 red.
According to our system of comparison, BGM is a better buy in the long-term than NDVAF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BGM’s TA Score shows that 3 TA indicator(s) are bullish.

  • BGM’s TA Score: 3 bullish, 6 bearish.

Price Growth

BGM (@Pharmaceuticals: Other) experienced а -21.76% price change this week, while NDVAF (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.02%. For the same industry, the average monthly price growth was +2.94%, and the average quarterly price growth was +92.60%.

Industries' Descriptions

@Pharmaceuticals: Other (+2.02% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BGM($24.7M) has a higher market cap than NDVAF($3.51M). BGM YTD gains are higher at: 18.698 vs. NDVAF (0.000). BGM has higher annual earnings (EBITDA): 3.28M vs. NDVAF (-5.09M). BGM has more cash in the bank: 11.9M vs. NDVAF (2.82M). BGM has less debt than NDVAF: BGM (13M) vs NDVAF (21.9M). BGM has higher revenues than NDVAF: BGM (59.2M) vs NDVAF (34.9M).
BGMNDVAFBGM / NDVAF
Capitalization24.7M3.51M704%
EBITDA3.28M-5.09M-64%
Gain YTD18.6980.000-
P/E Ratio15.98N/A-
Revenue59.2M34.9M170%
Total Cash11.9M2.82M421%
Total Debt13M21.9M59%
FUNDAMENTALS RATINGS
NDVAF: Fundamental Ratings
NDVAF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
72
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BGMNDVAF
RSI
ODDS (%)
Bullish Trend 5 days ago
68%
N/A
Stochastic
ODDS (%)
Bullish Trend 5 days ago
70%
N/A
Momentum
ODDS (%)
Bearish Trend 5 days ago
86%
N/A
MACD
ODDS (%)
Bearish Trend 5 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
89%
Bullish Trend 5 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
89%
Bullish Trend 5 days ago
89%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 6 days ago
88%
N/A
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
77%
N/A
Aroon
ODDS (%)
Bullish Trend 5 days ago
63%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
BGM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PACB1.600.11
+7.38%
Pacific Biosciences of California
TXMD1.180.04
+3.51%
TherapeuticsMD
BRZE28.780.61
+2.17%
Braze
TVRD22.460.31
+1.40%
Tvardi Therapeutics Inc
URI792.504.71
+0.60%
United Rentals

BGM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BGM has been closely correlated with APNHF. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if BGM jumps, then APNHF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BGM
1D Price
Change %
BGM100%
+2.77%
APNHF - BGM
73%
Closely correlated
N/A
MSTH - BGM
28%
Poorly correlated
N/A
SXTC - BGM
25%
Poorly correlated
+5.62%
CPIX - BGM
21%
Poorly correlated
-7.62%
YCBD - BGM
21%
Poorly correlated
-6.40%
More

NDVAF and

Correlation & Price change

A.I.dvisor tells us that NDVAF and ORGO have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NDVAF and ORGO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NDVAF
1D Price
Change %
NDVAF100%
N/A
ORGO - NDVAF
20%
Poorly correlated
+4.94%
TKNO - NDVAF
11%
Poorly correlated
+2.36%
MEDIF - NDVAF
9%
Poorly correlated
-3.53%
BGM - NDVAF
6%
Poorly correlated
+2.77%
OILFF - NDVAF
2%
Poorly correlated
+3.58%
More